Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Forte Biosciences, Inc.
Forte Biosciences has filed a Form 15 to terminate the registration of its Preferred Stock Purchase Rights and suspend its reporting obligations under Section 12(g) of the Securities Exchange Act. The company confirmed that there are zero record holders for this class of securities, effectively ending its duty to file related reports.…more
Forte Biosciences, Inc.
Forte Biosciences has finalized the termination of registration and suspension of reporting obligations under Section 12(g) of the Securities Exchange Act for its Pre-Funded Warrants. With zero record holders for these securities, the company has ceased its duty to file periodic reports regarding this class.…more
Forte Biosciences, Inc.
Forte Biosciences, Inc. has filed a Form 15 to terminate the registration of its common stock and suspend its reporting obligations under Section 12(g) of the Securities Exchange Act. The company confirmed that the number of record holders is currently one, resulting in the immediate cessation of its duty to file periodic reports with the SEC.…more
58 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
No news collected yet. New articles will appear here.